Moreover, when considering the role of FGF2 in the formation and maintenance of lymphatic vessels (19, 20), it is possible to hypothesize that PTX3 may inhibit FGF2-mediated lymphangiogenesis and its associated events, including tumor metastatic dissemination (107). This evidence concerns the gene FGF2 and neoplasm.